NASDAQ:SLGL Sol-Gel Technologies - SLGL Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. $5.17 +0.15 (+2.99%) (As of 02/3/2023 09:05 PM ET) Add Compare Share Share Today's Range$4.91▼$5.2050-Day Range$4.26▼$5.3252-Week Range$3.94▼$8.08Volume3,900 shsAverage Volume11,348 shsMarket Capitalization$119.58 millionP/E Ratio24.62Dividend YieldN/APrice Target$12.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Sol-Gel Technologies MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside141.8% Upside$12.50 Price TargetShort InterestBearish1.43% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.44Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.50) to ($0.32) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.22 out of 5 starsMedical Sector327th out of 1,025 stocksPharmaceutical Preparations Industry156th out of 498 stocks 3.5 Analyst's Opinion Consensus RatingSol-Gel Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.50, Sol-Gel Technologies has a forecasted upside of 141.8% from its current price of $5.17.Amount of Analyst CoverageSol-Gel Technologies has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted1.43% of the float of Sol-Gel Technologies has been sold short.Short Interest Ratio / Days to CoverSol-Gel Technologies has a short interest ratio ("days to cover") of 13.6, which indicates bearish sentiment.Change versus previous monthShort interest in Sol-Gel Technologies has recently increased by 3.58%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSol-Gel Technologies does not currently pay a dividend.Dividend GrowthSol-Gel Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SLGL. Previous Next 3.0 News and Social Media Coverage News SentimentSol-Gel Technologies has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Sol-Gel Technologies this week, compared to 0 articles on an average week.Search Interest3 people have searched for SLGL on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat Follows3 people have added Sol-Gel Technologies to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sol-Gel Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders66.51% of the stock of Sol-Gel Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 25.09% of the stock of Sol-Gel Technologies is held by institutions. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Sol-Gel Technologies are expected to grow in the coming year, from ($0.50) to ($0.32) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sol-Gel Technologies is 24.62, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.11.Price to Earnings Ratio vs. SectorThe P/E ratio of Sol-Gel Technologies is 24.62, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 150.32.Price to Book Value per Share RatioSol-Gel Technologies has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Sol-Gel Technologies (NASDAQ:SLGL) StockSol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.Read More Receive SLGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address SLGL Stock News HeadlinesFebruary 5, 2023 | americanbankingnews.comSol-Gel Technologies Ltd. (NASDAQ:SLGL) Expected to Earn Q1 2023 Earnings of ($0.25) Per ShareFebruary 2, 2023 | americanbankingnews.comSol-Gel Technologies (NASDAQ:SLGL) Given "Buy" Rating at HC WainwrightFebruary 6, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! January 27, 2023 | msn.comSol-Gel to acquire rare disorder drug patidegib for $4.7M upfront; plans $22.8M offeringsJanuary 27, 2023 | finance.yahoo.comSol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 MillionJanuary 27, 2023 | finance.yahoo.comSol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement OfferingsDecember 8, 2022 | finance.yahoo.comZacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel TechnologiesDecember 7, 2022 | finance.yahoo.com3 Generic Drug Stocks to Watch Amid Inflation PressuresFebruary 6, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! November 10, 2022 | finance.yahoo.comSol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 4, 2022 | finance.yahoo.comSol-Gel Technologies (NASDAQ:SLGL) investors are sitting on a loss of 45% if they invested a year agoOctober 24, 2022 | msn.comNasdaq Turns Higher; Applied Genetic Technologies Shares SurgeOctober 3, 2022 | finance.yahoo.comSol-Gel Technologies Appoints Michael Glezin Vice President, Business DevelopmentSeptember 19, 2022 | finance.yahoo.comAre Strong Financial Prospects The Force That Is Driving The Momentum In Sol-Gel Technologies Ltd.'s NASDAQ:SLGL) Stock?September 15, 2022 | reuters.comSol Gel Technologies LtdSeptember 12, 2022 | finance.yahoo.comZacks Industry Outlook Highlights Teva, Dr. Reddy's and Sol-GelSeptember 7, 2022 | nasdaq.comShareholders in Sol-Gel Technologies (NASDAQ:SLGL) are in the red if they invested a year agoAugust 4, 2022 | finance.yahoo.comSol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateJune 1, 2022 | finance.yahoo.comSol-Gel Technologies to Participate in the 2022 Jefferies Global Healthcare ConferenceMay 27, 2022 | finance.yahoo.comInvestors in Sol-Gel Technologies (NASDAQ:SLGL) have unfortunately lost 43% over the last yearMay 17, 2022 | finance.yahoo.comSol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment ConferenceMay 13, 2022 | finance.yahoo.comSol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate UpdateApril 25, 2022 | nasdaq.comSol-Gel Technologies Says FDA Approves EPSOLAY For Inflammatory Lesions Of RosaceaApril 25, 2022 | seekingalpha.comSol-Gel's stock rises as FDA approves Epsolay to treat skin condition rosaceaApril 14, 2022 | finance.yahoo.comSol-Gel Technologies Announces the Commercial Availability of TWYNEO®April 12, 2022 | finance.yahoo.comAre Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?March 30, 2022 | finance.yahoo.comSol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate DevelopmentsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SLGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address SLGL Company Calendar Last Earnings11/10/2022Today2/06/2023Next Earnings (Estimated)3/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SLGL CUSIPN/A CIK1684693 Webwww.sol-gel.com Phone(728) 931-3433Fax972-153-523044444Employees65Year FoundedN/APrice Target and Rating Average Stock Price Forecast$12.50 High Stock Price Forecast$19.00 Low Stock Price Forecast$5.50 Forecasted Upside/Downside+141.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.21 Trailing P/E Ratio24.62 Forward P/E RatioN/A P/E GrowthN/ANet Income$3.22 million Net Margins19.90% Pretax Margin19.90% Return on Equity9.62% Return on Assets8.45% Debt Debt-to-Equity RatioN/A Current Ratio18.31 Quick Ratio18.31 Sales & Book Value Annual Sales$31.27 million Price / Sales3.82 Cash Flow$0.20 per share Price / Cash Flow25.70 Book Value$2.73 per share Price / Book1.89Miscellaneous Outstanding Shares23,130,000Free Float7,746,000Market Cap$119.58 million OptionableNot Optionable Beta1.30 Key ExecutivesAlon Seri-LevyChief Executive Officer & DirectorItzik YosefChief Operating OfficerGilad MamlokChief Financial OfficerOfer ToledanoVice President-Research & DevelopmentOfra Levy-HachamVP-Clinical & Regulatory AffairsKey CompetitorsBriaCell TherapeuticsNASDAQ:BCTXMediciNovaNASDAQ:MNOVCleneNASDAQ:CLNNParatek PharmaceuticalsNASDAQ:PRTKIMARANASDAQ:IMRAView All CompetitorsInsiders & InstitutionsSimplex Trading LLCBought 500 shares on 2/2/2023Ownership: 0.000%MYDA Advisors LLCBought 70,400 shares on 11/10/2022Ownership: 0.304%Tower Research Capital LLC TRC Bought 4,387 shares on 11/10/2022Ownership: 0.024%View All Institutional Transactions SLGL Stock - Frequently Asked Questions Should I buy or sell Sol-Gel Technologies stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sol-Gel Technologies in the last year. There are currently 1 hold rating, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SLGL shares. View SLGL analyst ratings or view top-rated stocks. What is Sol-Gel Technologies' stock price forecast for 2023? 3 Wall Street research analysts have issued 12-month price objectives for Sol-Gel Technologies' stock. Their SLGL share price forecasts range from $5.50 to $19.00. On average, they predict the company's share price to reach $12.50 in the next twelve months. This suggests a possible upside of 141.8% from the stock's current price. View analysts price targets for SLGL or view top-rated stocks among Wall Street analysts. How have SLGL shares performed in 2023? Sol-Gel Technologies' stock was trading at $4.5599 at the start of the year. Since then, SLGL shares have increased by 13.4% and is now trading at $5.17. View the best growth stocks for 2023 here. When is Sol-Gel Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023. View our SLGL earnings forecast. How were Sol-Gel Technologies' earnings last quarter? Sol-Gel Technologies Ltd. (NASDAQ:SLGL) announced its quarterly earnings data on Thursday, November, 10th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.08. The company had revenue of $0.26 million for the quarter, compared to analysts' expectations of $3.45 million. Sol-Gel Technologies had a trailing twelve-month return on equity of 9.62% and a net margin of 19.90%. What other stocks do shareholders of Sol-Gel Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sol-Gel Technologies investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Flexion Therapeutics (FLXN), Iovance Biotherapeutics (IOVA), Marker Therapeutics (MRKR), Teva Pharmaceutical Industries (TEVA), Viking Therapeutics (VKTX), Verona Pharma (VRNA) and Adaptimmune Therapeutics (ADAP). When did Sol-Gel Technologies IPO? (SLGL) raised $60 million in an initial public offering (IPO) on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. Jefferies and BMO Capital Markets served as the underwriters for the IPO and JMP Securities and Raymond James were co-managers. What is Sol-Gel Technologies' stock symbol? Sol-Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL." Who are Sol-Gel Technologies' major shareholders? Sol-Gel Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of Sol-Gel Technologies? Shares of SLGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sol-Gel Technologies' stock price today? One share of SLGL stock can currently be purchased for approximately $5.17. How much money does Sol-Gel Technologies make? Sol-Gel Technologies (NASDAQ:SLGL) has a market capitalization of $119.58 million and generates $31.27 million in revenue each year. The company earns $3.22 million in net income (profit) each year or $0.21 on an earnings per share basis. How can I contact Sol-Gel Technologies? Sol-Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403648. The official website for the company is www.sol-gel.com. The company can be reached via phone at (728) 931-3433, via email at crusso@soleburytrout.com, or via fax at 972-153-523044444. This page (NASDAQ:SLGL) was last updated on 2/6/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.